Log in to save to my catalogue

Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activit...

Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed8d996137ea4d0e96be716da2a0fdb9

Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells

About this item

Full title

Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2025-02, Vol.16 (1), p.1905-16, Article 1905

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

A promising drug target, SETDB1, is a dual methyl-lysine (Kme) reader and methyltransferase implicated in cancer and neurodegenerative disease progression. To help understand the role of the triple Tudor domain (3TD) of SETDB1, its Kme reader, we first identify a low micromolar potency small molecule ligand, UNC6535, which occupies simultaneously b...

Alternative Titles

Full title

Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ed8d996137ea4d0e96be716da2a0fdb9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed8d996137ea4d0e96be716da2a0fdb9

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-025-57005-3

How to access this item